Cisplatin shortage results in substitution of more expensive treatments: Drug cost analysis

被引：0
|
作者：
Lam, Michael [1 ]
Olivier, Timothee
Haslam, Alyson [3 ]
Tuia, Jordan [3 ]
Prasad, Vinay [2 ,3 ,4 ]
机构：
[1] Univ Calif La Jolla, 9500 Gilman Dr, San Diego, CA 92093 USA
[2] Geneva Univ Hosp, Dept Oncol, 4 Gabrielle Perret Gentil St, CH-1205 Geneva, Switzerland
[3] Univ Calif San Francisco, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
[4] Mission Hall Global Hlth Clin Sci Bldg, Dept Epidemiol & Biostat, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 202卷
关键词：
D O I：
10.1016/j.ejca.2024.114019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] IS THE DRUG COST THE MAIN DRIVER FOR THE HIGH INCREMENTAL COST UTILITY RATIOS IN ONCOLOGY TREATMENTS? A SYSTEMATIC REVIEW AND A META-ANALYSIS
    Abouzid, A.
    VALUE IN HEALTH, 2014, 17 (07) : A662 - A662
  • [22] Is the Routine Use of Impedance Analysis for the Diagnosis of Gastro-Esophageal Reflux Disease More Expensive than Conventional pH Monitoring? Cost Analysis of Two Procedures
    Torer, Nurkan
    Aytac, Ozgur
    INDIAN JOURNAL OF SURGERY, 2017, 79 (03) : 192 - 195
  • [23] Is the Routine Use of Impedance Analysis for the Diagnosis of Gastro-Esophageal Reflux Disease More Expensive than Conventional pH Monitoring? Cost Analysis of Two Procedures
    Nurkan Törer
    Özgür Aytaç
    Indian Journal of Surgery, 2017, 79 : 192 - 195
  • [24] Using decision thresholds for ranking treatments in network meta-analysis results in more informative rankings
    Brignardello-Petersen, Romina
    Johnston, Bradley C.
    Jadad, Alejandro R.
    Tomlinson, George
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2018, 98 : 62 - 69
  • [25] ARE ACUTE THERAPIES AND CURATIVE DRUGS MORE AFFORDABLE THAN CHRONIC TREATMENTS IN RARE DISEASES? AN ANALYSIS OF THE TOP 10 MOST EXPENSIVE DRUGS IN THE US COMPARED WITH GERMANY
    Craddy, P.
    Hewitt, C.
    Foxon, G.
    VALUE IN HEALTH, 2023, 26 (12) : S189 - S189
  • [26] Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed
    Butler, Mark S.
    Gigante, Valeria
    Sati, Hatim
    Paulin, Sarah
    Al-Sulaiman, Laila
    Rex, John H.
    Fernandes, Prabhavathi
    Arias, Cesar A.
    Paul, Mical
    Thwaites, Guy E.
    Czaplewski, Lloyd
    Alm, Richard A.
    Lienhardt, Christian
    Spigelman, Melvin
    Silver, Lynn L.
    Ohmagari, Norio
    Kozlov, Roman
    Harbarth, Stephan
    Beyer, Peter
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (03)
  • [27] A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
    Narisa Tantai
    Usa Chaikledkaew
    Tawesak Tanwandee
    Pitsaphun Werayingyong
    Yot Teerawattananon
    BMC Health Services Research, 14
  • [28] A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
    Tantai, Narisa
    Chaikledkaew, Usa
    Tanwandee, Tawesak
    Werayingyong, Pitsaphun
    Teerawattananon, Yot
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [29] Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults
    Kee, Nicholas Ngan
    Foster, Emma
    Marquina, Clara
    Tan, Andy
    Pang, Samantha S. T.
    O'Brien, Terence J.
    Kwan, Patrick
    Jackson, Graeme D.
    Chen, Zhibin
    Ademi, Zanfina
    NEUROLOGY, 2023, 100 (18) : E1866 - E1877
  • [30] IMPACT OF THE DRUG USE AND SUBSTITUTION TREATMENTS ON THE ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C: ANALYSIS OF ADHERENCE, VIROLOGICAL RESPONSE AND QUALITY OF LIFE
    Melin, P.
    Lang, J. -P.
    Ouzan, D.
    Chousterman, M.
    Varastet, M.
    Rotily, M.
    Fontanges, T.
    Marcellin, P.
    Cacoub, P.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S233 - S233
12345